XY-4-88

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameXY-4-88
Drug Alias NameXY-4-88
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionProteolysisV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog modulators
TargetsGTPase KRas
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer InstituteUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer InstituteUniversity of Texas Southwestern Medical Center
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A